LON:CIR Circassia Group (CIR) Share Price, News & Analysis → New way to “hijack” stocks (From DTI) (Ad) Free CIR Stock Alerts GBX 34 -2.50 (-6.85%) (As of 09/2/2022) Add Compare Share Share Today's Range 33.75▼ 34.9050-Day Range 34▼ 3452-Week Range 29▼ 49.95Volume4,513 shsAverage Volume773,465 shsMarket Capitalization£142.66 millionP/E Ratio3,400.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Circassia Group alerts: Email Address Ad DTIThere’s only one solution to the impending energy catastrophe… Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! About Circassia Group Stock (LON:CIR)Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.Read More CIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CIR Stock News HeadlinesMay 24, 2024 | msn.comBTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled AsthmaMay 24, 2024 | msn.comBorder guards capture Russian soldier disguised in Ukrainian uniform in Donetsk Oblast – VideoJune 18, 2024 | WealthPress (Ad)Options expert shares his top option strategy for freeA 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.May 3, 2024 | thestreet.comCathie Wood buys $40 million of wounded tech stockMay 2, 2024 | lse.co.ukNiox Group Share ChatOctober 5, 2023 | finance.yahoo.comCircassia Group PLC (82C.SG)October 3, 2023 | msn.comDiscovering the Secrets of Da Vinci: Surprising Discovery About His Mother Unearthed in Historic Florence DocumentJuly 18, 2023 | marketwatch.comNIOX Group 1H Revenue Rose on Clinical Revenue IncreaseJune 18, 2024 | Crypto 101 Media (Ad)Catalyst Could Trigger 10,000% Crypto GainsAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. Just take a look:July 2, 2023 | insidermonkey.comBeyond Air, Inc. (NASDAQ:XAIR) Q4 2023 Earnings Call TranscriptJune 28, 2023 | benzinga.comGlobal Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives GrowthJune 8, 2023 | finance.yahoo.comChronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2023June 7, 2023 | marketwatch.comNIOX Group Declares 2.5p Special DividendMay 4, 2023 | marketwatch.comAllergy Immunotherapy Market Applications, Business Opportunities, and Strategies 2030April 13, 2023 | marketwatch.comHighlights 2028 Drug Allergy Treatments and Drugs Market: Regional Growth and New AdvancementApril 11, 2023 | fool.co.ukShould you buy Neil Woodford stock Circassia Pharmaceuticals after today’s price rise?March 17, 2023 | benzinga.comAsthma and COPD Drug Market Size Growing at 5.2% CAGR Set to Reach USD 60.3 Billion By 2032February 11, 2023 | msn.comWho are the Circassians of northern Israel?September 14, 2022 | lse.co.ukTRADING UPDATES: Epwin lifts interim payout; Anpario profit fallsSeptember 9, 2022 | barrons.comNIOX Group PLCAugust 11, 2022 | marketwatch.comCircassia Group to Seek Approval to Change Name to Niox GroupJuly 16, 2022 | marketwatch.comCircassia Group Expects to Report Swing to 1H Adjusted EbitdaJuly 14, 2022 | lse.co.ukAIM WINNERS & LOSERS: Kibo extends contract; Appreciate CEO steps downJuly 14, 2022 | lse.co.ukCircassia ups guidance as revenue rises, overhead costs slashedJuly 3, 2022 | fool.co.ukCircassia PharmaceuticalsJuly 1, 2022 | msn.comSMALL CAP MOVERS: Deltic Energy shares rise on rig contract with Shell; Oxford BioDynamics sinks as it might need further fundingJuly 1, 2022 | msn.comSMALL CAP MOVERS: Deltic Energy; Oxford BioDynamicsSee More Headlines Receive CIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Circassia Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/17/2020Today6/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:CIR CUSIPN/A CIKN/A Webwww.circassia.co.uk Phone44 1865 405 560FaxN/AEmployees111Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio3,400.00 Forward P/E Ratio35.79 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.95 Current Ratio1.83 Quick Ratio1.50 Sales & Book Value Annual Sales£27.90 million Price / Sales5.11 Cash FlowGBX 3 per share Price / Cash Flow11.33 Book ValueGBX 16 per share Price / Book2.13Miscellaneous Outstanding Shares419,578,000Free FloatN/AMarket Cap£142.66 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Ian Roy Johnson (Age 68)Exec. Chairman Comp: $303kMr. Michael Roy David Roller A.C.A. (Age 57)ACA, BA (Hons), CFO & Director Comp: $224kMr. Jonathan EmmsCOO & Exec. DirectorMs. Nina KatariaSr. VP Global HRMs. Sarah DuncanCompany Sec.Key CompetitorsSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDVerona Pharma plc (VRP.L)LON:VRP4basebioLON:4BBView All Competitors CIR Stock Analysis - Frequently Asked Questions How have CIR shares performed in 2024? Circassia Group's stock was trading at GBX 34 at the beginning of the year. Since then, CIR stock has increased by 0.0% and is now trading at GBX 34. View the best growth stocks for 2024 here. How were Circassia Group's earnings last quarter? Circassia Group Plc (LON:CIR) issued its earnings results on Thursday, September, 17th. The company reported ($3.00) earnings per share for the quarter. What other stocks do shareholders of Circassia Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Circassia Group investors own include EnQuest (ENQ), boohoo group (BHOOY), Cummins (CMI), FutureFuel (FF), Trade Desk (TTD), Ascential (ASCL), H&T Group (HAT), Howden Joinery Group (HWDN), NMC Health (NMC) and Oxford Biomedica (OXB). How do I buy shares of Circassia Group? Shares of CIR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CIR) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Circassia Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Circassia Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
